Apixaban

Findings from a real-world data analysis of the U.S. Medicare database comparing the risk of stroke or systemic embolism and...


Amid growing uncertainty about the safety of Digoxin, a commonly used heart drug, a study led by Duke Clinical Research...


In addition to Warfarin ( Coumadin ), there are four non-vitamin K antagonist oral anticoagulants ( NOACs ) available for...


Apixaban ( Eliquis ), a direct factor Xa inhibitor approved for thromboembolic prophylaxis in patients with non-valvular atrial fibrillation, is...


History of bleeding strongly influences decisions for anticoagulation in atrial fibrillation. Researchers have analyzed outcomes in relation to history of...


Historically, Warfarin ( Coumadin ) or Acetylsalicylic acid ( Aspirin ) have been the recommended therapeutic options for the extended...


The first non-vitamin K antagonist oral anticoagulant ( NOAC ) introduced to the market in Japan was Dabigatran ( Pradaxa...


Case reports and analyses of clinical studies and of pharmacovigilance data suggest that new oral anticoagulants ( NOACs ) are...


A study has compared efficacy and safety among novel oral anticoagulants ( NOACs ), which have not been directly compared...


In the Apixaban for Prevention of Acute Ischemic Events ( APPRAISE-2 ) trial, the use of Apixaban ( Eliquis ),...


Non-vitamin K antagonist oral anticoagulants ( NOACs ) are efficacious and safe antithrombotic drugs but the non-availability of an antidote...


The new oral anticoagulants ( NOACs ) Dabigatran etexilate ( Pradaxa ), Rivaroxaban ( Xarelto ), and Apixaban ( Eliquis...


The results from two analyses of the GLORIA-AF Registry Program examining the use of antithrombotic treatment to reduce the risk...


The first non-vitamin K antagonist oral anticoagulant ( NOAC ) introduced to the market in Japan was Dabigatran ( Pradaxa...


Apixaban ( Eliquis ) is a novel oral anticoagulant which is approved for the management of atrial fibrillation and venous...


The coagulation system contributes greatly to the evolution of myocardial infarction ( MI ). Anticoagulation may reduce the occurrence of...


Amiodarone ( Cordarone ) is an effective medication in preventing atrial fibrillation ( AF ), but it interferes with the...


Venous thromboembolism ( VTE ) often complicates the clinical course of cancer. The risk is further increased by chemotherapy, but...


For patients with atrial fibrillation or atrial flutter of 48-hour duration or longer, or when the duration of atrial fibrillation...


Bristol-Myers Squibb ( BMS ) and Pfizer have announced results of a pre-specified subanalysis of the phase 3 ARISTOTLE trial...